logo

For the Inventor, By the Inventor

San Carlos, CA, United States of America

Alkahest, Inc.


USPTO Granted Patents = 26



Trademarks = 9

Forward Citations = 60

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Steven P Braithwaite (9 out of 12 patents)

silverMedal Eva Czirr (8 out of 8 patents)

bronzeMedal S Sakura Minami (8 out of 8 patents)

4.  Viktoria Kheifets (8 out of 15 patents)

5.  Ian Gallager (7 out of 7 patents)

6.  Benson Lu (7 out of 7 patents)

7.  Karoly Nikolich (5 out of 7 patents)

8.  Meghan Kerrisk Campbell (5 out of 5 patents)

9.  Nina Huber (4 out of 4 patents)

10.  Sam Jackson (3 out of 3 patents)

11.  Balazs Szoke (2 out of 2 patents)

12.  Anton Wyss-Coray (2 out of 20 patents)

13.  Saul A Villeda (2 out of 6 patents)

14.  Marian Castro (2 out of 2 patents)

15.  Joseph McCracken (2 out of 2 patents)


26 patents:

1. 12496296 - Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases (2025-12-16),
2. 12059453 - Blood plasma fractions for use in muscle regeneration (2024-08-13),
3. 12053489 - Blood plasma fractions for use in liver regeneration (2024-08-06),
4. 11957671 - Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases (2024-04-16),
5. 11951102 - Methods and compositions for treating retina-associated disease using CCR3-inhibitors (2024-04-09),
6. 11660316 - Methods of inducing liver regeneration by administering a plasma protein fraction (2023-05-30),
7. 11612596 - Pharmaceutical formulations comprising CCR3 antagonists (2023-03-28),
8. 11590118 - Methods and compositions for treating retina-associated disease using CCR3-inhibitors (2023-02-28),
9. 11547724 - Methods of treating a subject for pain (2023-01-10),
10. 11484551 - Method of treating liver failure with plasma fraction IV-4 (2022-11-01),
11. 11439687 - Blood plasma fractions for use in muscle regeneration (2022-09-13),
12. 11426399 - Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase (2022-08-30),
13. 11413308 - Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products (2022-08-16),
14. 11382907 - Methods and compositions for treating aging-associated impairments using CCR3-inhibitors (2022-07-12),
15. 11344542 - Treatment of aging-associated disease with modulators of leukotriene Ahydrolase (2022-05-31),
Alkahest, Inc. is a biotechnology company that specializes in developing therapies to target neurodegenerative disorders and age-related diseases. With a focus on understanding the role of blood in aging, Alkahest seeks to identify and develop innovative treatments derived from a deep understanding of the plasma proteome. Through cutting-edge research and collaboration with leading academic institutions, Alkahest aims to revolutionize the field of aging and improve human health and longevity.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

...
26 Patents

#9 in San Carlos, CA

#2,960 in California

#12,467 in US

#24,137 in the World

...
San Carlos, CA, United States of America

Alkahest, Inc.

Forward Citations = 60

23 inventors:

goldMedal Steven P Braithwaite (9 out of 12 patents)

silverMedal Eva Czirr (8 out of 8 patents)

bronzeMedal S Sakura Minami (8 out of 8 patents)

4.  Viktoria Kheifets (8 out of 15 patents)

5.  Ian Gallager (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…